SubHero Banner
Text

Folotyn®(pralatrexate) – First-time authorized brand alternative

November 17, 2022 - Fresenius launched an authorized brand alternative (ABA) of Acrotech Biopharma’s Folotyn (pralatrexate) injection.

Download PDF

Text